Ellinor Patrick Thomas II
Transaction: 08/06/2026
OTHER
Change
0
Price
Not reported
Filing
08/07/2026
Type
OTHER
Editas Medicine, Inc.
EDIT • Biotechnology
$3.23
▲ +0.15 (+4.87%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$385.32M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 3.54High debt level · 2.81Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:45 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.23
Change4.87%
Shares Out119.29M
Market Cap$385.32M
Enterprise Value$173.68M
52W Range1.66 - 4.54
Beta2.10
P/E-5.21
P/S10.97
P/B3.66
P/FCF-2.68
EV/Sales4.95
Price$3.23
Change4.87%
Shares Out119.29M
Market Cap$385.32M
Enterprise Value$173.68M
52W Range1.66 - 4.54
Beta2.10
P/E-5.21
P/S10.97
P/B3.66
P/FCF-2.68
EV/Sales4.95
EV/EBITDA-3.35
EV/FCF-1.21
Earnings Yield-19.19%
FCF Yield-37.29%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-2.45%
Profit Margin-3.95%
Debt/Eq2.81
Current Ratio3.54
Quick Ratio3.54
Target$5.00
Target Upside54.80%
Target Median$5.00
Target Range4.00 - 6.00
Volume1.63M
Avg Volume2.21M
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
69/100
Price Attractiveness
Cheap or expensive today
57/100
Why this score▼
Healthy liquidity · 3.54High debt level · 2.81Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 25 analyst votes · 2026-09-05
74/100
Bullish
Bullish
14
Hold
9
Bearish
2
Price Target
2026-08-13
Low
$4.00
Mean
$5.00
Median
$5.00
High
$6.00
Insider Transactions
Recent executive and insider activity
Ellinor Patrick Thomas II
Transaction: 08/06/2026
BUY
Change
+103,400
Price
$2.90
Filing
08/07/2026
Type
BUY
Parison Amy
Transaction: 08/03/2026
SELL
Change
-678
Price
$2.58
Filing
08/05/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Ellinor Patrick Thomas II | OTHER | 0 | Not reported | 08/06/2026 | 08/07/2026 |
| Ellinor Patrick Thomas II | BUY | +103,400 | $2.90 | 08/06/2026 | 08/07/2026 |
| Parison Amy | SELL | -678 | $2.58 | 08/03/2026 | 08/05/2026 |
| Burkly Linda | SELL | -4,928 | $2.67 | 07/28/2026 | 07/29/2026 |
| Levy Elliott M. | BUY | +51,700 | $2.55 | 06/17/2026 | 06/22/2026 |
| Scadden David | BUY | +51,700 | $2.55 | 06/17/2026 | 06/22/2026 |
| Hirsch Andrew | BUY | +51,700 | $2.55 | 06/17/2026 | 06/22/2026 |
| Hopfield Jessica | BUY | +51,700 | $2.55 | 06/17/2026 | 06/22/2026 |
| Connaughton Bernadette | BUY | +51,700 | $2.55 | 06/17/2026 | 06/22/2026 |
| Burkly Linda | SELL | -731 | $2.70 | 06/03/2026 | 06/05/2026 |
| O'Neill Gilmore Neil | SELL | -15,380 | $2.70 | 06/03/2026 | 06/05/2026 |
| Parison Amy | SELL | -464 | $2.70 | 06/03/2026 | 06/05/2026 |
| Burkly Linda | BUY | +292,856 | $2.54 | 03/12/2026 | 03/16/2026 |
| Parison Amy | BUY | +292,856 | $2.54 | 03/12/2026 | 03/16/2026 |
| O'Neill Gilmore Neil | BUY | +1,015,200 | $2.54 | 03/12/2026 | 03/16/2026 |
| Burkly Linda | SELL | -749 | $2.02 | 03/03/2026 | 03/04/2026 |
| Parison Amy | SELL | -474 | $2.02 | 03/03/2026 | 03/04/2026 |
| O'Neill Gilmore Neil | SELL | -5,394 | $2.02 | 03/03/2026 | 03/04/2026 |
| Parison Amy | SELL | -461 | $2.15 | 12/03/2025 | 12/04/2025 |
| O'Neill Gilmore Neil | SELL | -5,603 | $2.15 | 12/03/2025 | 12/04/2025 |